SI-BONE, Inc.

NasdaqGM SIBN

SI-BONE, Inc. Receivables for the quarter ending September 30, 2024: USD 24.91 M

SI-BONE, Inc. Receivables is USD 24.91 M for the quarter ending September 30, 2024, a 24.62% change year over year. Receivables are the amounts owed to the company by customers for goods sold or services rendered.
  • SI-BONE, Inc. Receivables for the quarter ending September 30, 2023 was USD 19.99 M, a 21.49% change year over year.
  • SI-BONE, Inc. Receivables for the quarter ending September 30, 2022 was USD 16.45 M, a 30.40% change year over year.
  • SI-BONE, Inc. Receivables for the quarter ending September 30, 2021 was USD 12.62 M, a 10.51% change year over year.
  • SI-BONE, Inc. Receivables for the quarter ending September 30, 2020 was USD 11.42 M, a 15.11% change year over year.
Key data
Date Receivables Inventory Goodwill Total Assets
Market news
Loading...
NasdaqGM: SIBN

SI-BONE, Inc.

CEO Ms. Laura A. Francis MBA
IPO Date Oct. 17, 2018
Location United States
Headquarters 471 El Camino Real
Employees 344
Sector Health Care
Industries
Description

SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.

Similar companies

OFIX

Orthofix Medical Inc.

USD 17.51

0.81%

NPCE

NeuroPace, Inc.

USD 11.84

-2.23%

SGHT

Sight Sciences, Inc.

USD 3.15

-2.78%

AXGN

AxoGen, Inc.

USD 18.24

-0.06%

CNMD

CONMED Corporation

USD 67.79

-2.46%

IRMD

IRadimed Corporation

USD 57.52

1.79%

TCMD

Tactile Systems Technology, Inc.

USD 17.46

1.51%

ESTA

Establishment Labs Holdings Inc.

USD 33.15

-1.66%

ITGR

Integer Holdings Corporation

USD 138.83

2.72%

KIDS

OrthoPediatrics Corp.

USD 23.55

-5.80%

RXST

RxSight, Inc.

USD 30.08

-2.08%

TMCI

Treace Medical Concepts, Inc.

USD 8.01

-4.19%

LUNG

Pulmonx Corporation

USD 6.84

-2.98%

StockViz Staff

January 15, 2025

Any question? Send us an email